Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-07-007248
Filing Date
2007-08-06
Accepted
2007-08-06 10:52:43
Documents
9

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC. g06286a5sv1za.htm S-1/A 2039073
2 EX-4.1 SPECIMEN COMMON STOCK CERTIFICATE g06286a5exv4w1.htm EX-4.1 1407
3 EX-10.1 MANUFACTURING AND SUPPLY AGREEMENT g06286a5exv10w1.htm EX-10.1 149581
4 EX-23.1 CONSENT OF KPMG LLP g06286a5exv23w1.htm EX-23.1 2805
5 EX-23.3 CONSENT OF MORGAN JOSEPH & CO INC. g06286a5exv23w3.htm EX-23.3 1627
6 GRAPHIC g06286a5g0628602.gif GRAPHIC 3768
7 GRAPHIC g06286a5g0628640.jpg GRAPHIC 1810318
8 GRAPHIC g06286a5g0628641.jpg GRAPHIC 489246
9 GRAPHIC g06286a5g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-07-007248.txt   5370413
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 071026181
SIC: 2834 Pharmaceutical Preparations